Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;80(6):817-819.
doi: 10.1136/annrheumdis-2020-219808. Epub 2021 Jan 12.

SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease

Affiliations

SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease

Kristin M D'Silva et al. Ann Rheum Dis. 2021 Jun.
No abstract available

Keywords: COVID-19; autoimmune diseases; epidemiology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JAS reports research support from Amgen and Bristol-Myers Squibb and consultancy fees from Bristol-Myers Squibb, Gilead, Inova, Janssen, Optum and Pfizer. ZSW reports research support from Bristol-Myers Squibb and Principia and consulting fees from Viela Bio and MedPace. All other authors report no competing interests.

Comment in

References

    1. Lumley SF, O’Donnell D, Stoesser NE, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med Overseas Ed 2020. - PMC - PubMed
    1. , Horby P, Lim WS, Landray MJ, et al. , RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med 2020. doi: 10.1056/NEJMoa2021436. [Epub ahead of print: 17 Jul 2020]. - DOI - PMC - PubMed
    1. Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus Remdesivir for hospitalized adults with Covid-19. N Engl J Med 2020. doi: 10.1056/NEJMoa2031994. [Epub ahead of print: 11 Dec 2020]. - DOI - PMC - PubMed
    1. Kaneko N, Kuo H-H, Boucau J, et al. Loss of Bcl-6-Expressing T follicular helper cells and germinal centers in COVID-19. Cell 2020;183:143–57. - PMC - PubMed
    1. Choi B, Choudhary MC, Regan J, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med 2020;383:2291–3. - PMC - PubMed

Publication types